ATAZANAVIR
- Product NDC
- 59762-0408
- 11-digit product format
- 597620408
- Labeler code
- 59762
- Product ID
- 59762-0408_31600e95-44e5-45da-bec8-ae4f596409fb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ATAZANAVIR
- Dosage form
- CAPSULE, GELATIN COATED
- Route
- ORAL
- Labeler
- Greenstone LLC
- Application
- NDA021567
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2018-01-02
- Marketing end
- 0000-00-00
- Substance
- ATAZANAVIR SULFATE
- Active strength
- 150 mg/1
- Pharmacologic classes
- HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record